午夜一级毛片-手机看片99-动漫人物桶机免费动漫app-日日摸日日碰夜夜97|www.zyjlr.com

TEL:020-31701980      FAX:020-31701979     E-mail:sales@mx008.com
China Mingxuan
Service Hotline:020-3171980
搜索

News
MX trends
industry trends
fair information
 
Micro-channel
 
Information details You are here:Home >> News >> industry trends
 
The drug generation of drug administration for the preparation of drug administration in gansu province has been reduced to 600,000
 
Author:中國銘鉉 企劃部  Release Time:2017-9-8 15:08:15  Number Browse:900
 
On September 8th, the pharmaceutical network of gansu province was released on behalf of the management platform of medical representatives, and the total number of real medical representatives in the country may be between 300,000 and 600,000.

Recently, the gansu province government general office issued documents, to strengthen the administration of pharmaceutical representatives for the record, set up "on behalf of pharmaceutical management platform", and make clear a regulation on October 1, the full implementation of "two votes".

▍ preparation medicine generation of filing management platform in gansu province

Office of gansu province government issued "on further reform and improve the pharmaceutical production circulation use policy implementation opinion", which make the arrangement from the content to a medical representative for the record, and the national documents is roughly same, involved in four aspects: the record management, information disclosure, and shall not bear the sales task, blacklist system.

Compared to the already take part in the implementation of the Shanghai, gansu province, the files for a specific punishment is not detailed, specific in gansu province for irregularities will be how to deal with drug promotion, now not the suspense.

In addition to Shanghai and gansu provinces, some hospitals in zhengzhou have started to carry out drug generation records, and it is likely that the drug generation filing system will be implemented nationwide in the near future.

▍ for archival filing, medicine generation of mixed emotions

For the medical representative filing system, cypress blue through the activity visit discovery, many drug generation in the heart is like the oil salt sauce vinegar all mixed together, the five flavors of miscellaneous Chen.

A drug firms a medical representative training personnel to Mr Pang said to the blue parker, watching the filing system to implement, we have a lot of problems did not understand, for example, as for the record to the requirement of medicine is what generation of professional, is all drug can record? Only one part of the drug generation is qualified for the record; For example, there are many hospitals now, setting up special agent reception room, installing face recognition system, many drug generations are afraid to record, if not put on record, is the drug generation qualified to work?

Many CSO executives are even more anxious about the company's future. For example, one of them said to cyberan, the policy requires pharmaceutical representatives to register with the company. If pharmaceutical companies choose to file their own business, will they still need CSO?

In addition, the person in charge is another concern, CSO a medical representative of the company often acting several kinds of products, if the medicine generation for the record which company they put on record? If the record is filed, if the drug company is to promote the product of the drug company, the registration is another company, how should such a situation be determined?

With this suspicion, some pharmaceutical workers even suggested that it would not be a tool for drug companies to attack each other.

I personally think that, in the face of medicine generation of filing system, the personage inside course of study though there are such, that kind of uncertainty, but what is certain is that the pharmaceutical filing system is bows are full, the arrows are few were off.

Under the wave of compliance, GSK's staff at the central government affairs department Shared GSK's compliance experience with the drug generation. There are three main points, one is to exclude motive (performance is not linked to sales index); Second, control means (no cash); Third, management (emphasis on scientific management).

With the incentives and means, the gold sales came into being, but it was not a Chinese feature.

According to senior industry experts, the us drug generation has been sold for eight years, and Taiwan drug generation has been sold for 12 years, and mainland drug generation has been sold for 20 years.

From this set of data, we can see that the non-compliance can only be a while, and can never be kept for a lifetime.

In addition, there is a set of data, which is quite thought-provoking. , according to a senior medicine generation of general theory is that Chinese medicine has 3 million generation, look from actual condition, we may also accords with a requirement of 300000 ~ 600000, overall, the gap between medicine and doctors.

It is hard to imagine how much this would be if the medical representative's filing system came to a full end. How many drugs are not one of them?

▍ attached: general office of gansu province people's government on further reform and improve the pharmaceutical production circulation use policy implementation opinions

The people's governments of various cities and autonomous prefectures, the administrative committee of lanzhou new district, the relevant departments of the provincial government, and the central government in gump:

For the implementation of the general office of the state council on further reform and improve the pharmaceutical production circulation use policy several opinions (countries do hair [2017] no. 13), effectively raise the quality of the provincial drug curative effect, standardize the order of pharmaceutical production circulation, purifying the circulation environment, regulate the behavior of drug use, and better serve the needs of the masses of the people to see, the all-round health of gansu construction, subject to consent by the provincial government, combined with our province reality, put forward the following implementation opinions.

First, improve the quality of medicine and promote the structural adjustment of pharmaceutical industry

(1) to manage and serve drug registration.

We will strengthen drug review and acceptance, on-site inspection, technical review and assessment, advance service pass, and strengthen business guidance and technical services for enterprises. We will optimize drug acceptance and review procedures and speed up the acceptance of new drugs and generic drugs. Strengthen drug registration and development site verification and production site inspection data verification, and severely punish data fraud. (responsibility unit: provincial food and drug administration)

(2) to guide and encourage drug manufacturers to carry out generic drug quality and efficacy consistency evaluation work according to relevant guiding principles.

Using the existing special funds, the enterprises that pass the evaluation will be given certain financial support. The imported reference preparation for the study of the consistency evaluation study, expedite the examination and approval coordination, and improve the efficiency of customs clearance. To guide qualified medical institutions, institutions of higher learning, scientific research institutions and other social inspection and testing institutions to conduct consistent assessment of bioequivalence in accordance with law. Medical institutions should take priority in procurement through consistent evaluation of drug varieties. The production enterprises with the consistency evaluation of the same variety of drugs have reached more than 3, and the varieties with no consistency evaluation are not selected in the areas of drug concentration procurement. (responsible department: provincial food and drug administration, provincial information commission, provincial finance department, provincial science and technology department, provincial social hall)

(3) to promote the pilot work of drug listing permit holder system.

Learn from drug marketing authorisation holder pilot experience and practice of provinces and cities, to carry out publicity and training, combined with our province science and technology innovation policy, encourage drug research institutes, institutions of higher learning, scientific research personnel, such as research and development of new drugs, promote new products, new technology, the scientific research project and existing capacity, stimulate the enthusiasm of each innovation main body participation in scientific and technological innovation and initiative. (responsibility department: provincial food and drug administration, provincial science and technology department)

(4) strengthen supervision over the quality and safety of drug production.

1. Strengthen supervision and inspection of drug production. We urge enterprises to strictly implement the quality management standard of pharmaceutical products (hereinafter referred to as GMP) to faithfully record the information of the production process and ensure that the data is authentic, complete, accurate and traceable. The company should fully verify the change of raw material and the adjustment of production process. Emphasize main responsibility, strictly implement the system of quality of the right person. Perfect "double random, a public" supervision and management mechanism, strengthen supervision and inspection on pharmaceutical production enterprise implement GMP, ensure the basic drugs production enterprise supervision and inspection of not less than 2 times a year, the key supervision enterprise tracking check 1 time every year, no less than 10% of the proportion of other random track inspection. We will step up the testing of high-risk varieties and traditional Chinese medicine tablets, timely dispose of the problems found in the sampling inspection and inspection, and control the risks in a controllable range. We will improve the reporting system for drug supervision and inspection and publicize the results to the public in a timely manner. (responsibility unit: provincial food and drug administration)

2. Crack down on the illegal and criminal behavior of counterfeit and shoddy medicines. Public security cooperation mechanism, improve the food and drug supervision and do a better job of administrative law enforcement and criminal justice and cohesion, to timely transferred to the public security organs, the alleged to focus on the case publicly listed online supervisory, severely punished according to law, exert to investigate and punish, education a deterrent effect. The public security organs shall promptly notify the drug supervision and administration departments to take the next steps and recall measures to prevent the continuation of the damage to the society. We will increase the exposure of illegal and illegal activities, and clarify the procedures and requirements for the information and public exposure of local regulatory authorities. (responsibility unit: provincial food and drug administration, provincial public security department)

(5) strengthen the restructuring of the pharmaceutical industry.

1. Support enterprises to carry out technological innovation. We will support qualified enterprises and research institutes to declare national science and technology programs (special funds, etc.) for major new drugs, and improve the drug innovation capacity and quality of our province. Strengthen the ability construction of drug research and development in our province, to speed up the transformation of scientific research achievements, guidance, support to developed on the basis of traditional Chinese medicine new drug of TCM, the resources of traditional Chinese medicine in our province industrial structure adjustment and optimization of configuration. (responsibility unit: provincial science and technology department, provincial health and family planning commission, provincial commission of industry and information technology, provincial food and drug administration)

2. Actively cultivate the brand of longyao industry. Encourage and guide the pharmaceutical industry is concentrated, the condition is relatively mature area to carry out the construction of "national well-known brands to create demonstration zone", further improve the level of industry intensive, brand development, enhance the competitiveness of the pharmaceutical industry in our province and the brand influence. Support enterprise participation in the brand value evaluation, distribution, promotion, technical services and other activities, the implementation of brand strategy, actively strive for brand-name products in gansu province and the provincial government quality prize, enhance brand value, promote to build domestic and international famous brands. (responsible unit: provincial quality supervision bureau, provincial information commission, provincial science and technology department, provincial food and drug administration)

3. Optimize the layout and planting structure of Chinese medicinal materials. We should adhere to the principle that traditional Chinese medicine concentrates on the concentrated and valuable rare medicinal herbs in producing areas of eugenics, and focuses on supporting the varieties and producing areas of Chinese medicinal materials. We will vigorously promote the standardization of traditional Chinese medicinal materials and encourage the formation of an integrated production model of "enterprise + base + farmers". Support Chinese medicinal materials processing enterprises and cooperative circulation land, construction scale, standardized production demonstration base. Through the guidance of policy and funding support, encourage social capital investment, Chinese herbal medicine industry bigger and stronger a batch of powerful economic strength, a well-known brand in the market, the standardized planting base of Chinese medicinal materials deep processing enterprises. We will popularize safe storage technology, extend the listing period of Chinese medicinal materials, stabilize the sales price of the products and stabilize the income of pharmaceutical farmers. We will improve the breeding system of Chinese medicinal herbs, and support the improvement and purification of traditional Chinese medicinal herbs, and cultivate and promote fine varieties. We will strengthen the protection of wildlife resources and realize the sustainable development of medicinal resources. (responsibility department: provincial agriculture and herding hall, provincial industry and information commission, provincial food and drug administration)

(6) ensure the effective supply of drugs.

1. Improve the shortage of drugs, cheap drugs monitoring and warning and grading coping mechanism, establish and improve shortage of collect, transmit, analysis, drug information consultation system, dynamic master key enterprise production situation, as a whole to fixed-point production, pharmaceutical reserve, emergency production, negotiate, adjust measures, such as ensuring the supply of drug market. We will implement the monthly reporting system for shortage medicines, and urge 276 provincial, municipal, county and township monitoring points to report shortages of drug information. Improve the system of emergency procurement, strengthen emergency procurement management, adjust the catalog of gansu provincial pharmaceutical reserve varieties, so as to adapt to the first aid, detoxification, shortage of normal drugs and disasters, plagues and emergency supplies. Dynamically adjust the catalog of gansu province directly net drug list (shortage), improve the shortage of medicine information connectivity platform, in order to further guarantee the supply of shortage of emergency drugs do a good job. (responsible unit: provincial health and family planning commission, provincial commission of industry and information, provincial Commerce Department, provincial food and drug administration)

2. Strengthen supervision over narcotic drugs, psychotropic substances and compound preparations containing special medicines. Strictly carry out the special pharmaceutical trading enterprises in apt information reporting system by state food and drug supervision bureau, approval number entry review and detailed report for purchase and marketing system, strengthen the production and management of narcotic drugs and psychotropic drugs the supervision and management of the enterprise and the use of units, to carry out the inspection frequency and regularly submit system, ensure the safety of narcotic drugs and psychotropic drugs. (responsibilities: provincial food and drug administration, provincial health and family planning commission, provincial public security department)

3. Support the use of traditional Chinese medicine formulations for the reliable and effective medical institutions. The application of traditional Chinese medicine preparation of traditional Chinese medicine preparation is put on record. The medical institutions should strengthen the monitoring and reporting of the adverse reactions of Chinese traditional Chinese medicine preparations. The pharmaceutical supervisory and administrative departments shall strengthen the supervision and inspection of the preparation and use of the varieties of traditional Chinese medicines. (responsibility unit: provincial food and drug administration, provincial health and family planning commission)

Second, rectify the drug circulation order and promote the reform of drug circulation system

(7) promoting the transformation and upgrading of drug distribution enterprises.

1. In order to improve the industry concentration and organizational degree as the guidance, encourage and support the conditional medicine circulation enterprises through merger, combination in the form of equity participation, holding to the development of large-scale, collectivization and intensive management, speed up the promotion enterprise scale strength, enhance market competitiveness. We will encourage the orderly construction of a batch of socialized, specialized and modern pharmaceutical logistics distribution centers by the competent and qualified pharmaceutical circulation enterprises. We will encourage large drug distribution enterprises in the province to set up warehouses, integrate small and medium-sized drug distribution enterprises to store and transport resources, and improve drug delivery and distribution services; We will encourage small and medium-sized pharmaceutical companies to transform their distribution distribution models to meet the needs of the multi-level drug market. (responsibility unit: provincial department of commerce, ministry of industry and information technology, provincial food and drug administration)

2. Promote the operation of drug retail enterprises and implement classification management. We will encourage pharmaceutical wholesalers to start drug retail chains, implement wholesale and retail operations, and encourage independent drugstores to join retail chains and increase the retail chain rate. We will further optimize the management of drug retail classification, and promote the chain, standardization, scale and informatization of retail pharmacies. (responsibility unit: provincial food and drug administration, provincial Commerce Department)

(8) implement drug purchase and marketing "two-ticket" system.

1. Fully implement the "two-ticket system". We will actively yet prudently advance the implementation of the "two-ticket system" through drug classification, medical institution classification and regional division. Province tertiary public hospital on October 1, 2017, fully implement the "two votes", secondary public medical institutions in the new drug centralized purchasing the bidding result perform the full implementation of the "two votes", put in place before the end of 2018. All localities and relevant departments should actively create favorable conditions for the arrival of the "two-ticket system", break down local protection, clean up and abolish unreasonable policies and regulations that hinder the healthy development of the pharmaceutical circulation industry. Drug distribution enterprises and medical institutions shall establish a complete record of purchase and sale of information for purchase and sale of goods, and shall be in line with the documents, accounts, goods and payment of goods, and accompany them to their counterparts. Development "invoice maintenance and query system", the establishment of drug purchase information, invoice, along with the electronic goods peer information query, validation, and traceability, exploring and tax departments such as electronic invoice the connectivity of information, realize electronic "two votes" inspection. (responsibilities: provincial health and family planning commission, provincial food and drug administration, provincial development and reform commission, provincial Commerce Department, internal revenue service)

2. Strengthen supervision over the implementation of the two-ticket system. The implementation of the "two-ticket system" of drug production, circulation enterprises and public medical institutions shall be included in the scope of daily supervision and inspection. The food and drug supervision and administration departments at all levels to medicine circulation enterprises to implement the "two votes" is included in the scope of supervision and inspection, in violation of the provisions of the "two votes" of the enterprise, it shall timely treatment, and notify the provincial health and family planning commission and the provincial drug procurement agencies. The tax authorities should strengthen the pharmaceutical production, circulation enterprises and medical organizations of invoice management, strengthen auditing of tax evasion in accordance with the law and to create conditions for "electronic invoice" sharing the Internet, to provide support. The financial departments at all levels shall support the construction and operation costs of the "two-ticket" electronic information tracing system. To crack down on monopolistic behavior, unfair competition and infringement of the legitimate rights and interests of consumers. (responsibility: provincial health and family planning commission, provincial food and drug administration, provincial development and reform commission, provincial finance department, internal revenue service)

(9) improve the drug purchasing mechanism.

Full implementation of drug classified purchasing policy, according to the principle of transparency, fair competition, science set up the evaluation factors, further improve the participation in the drug centralized purchasing of medical institutions, and encourage hospital joint procurement. We will strengthen the linkage between drug purchasing and medicare payment, leverage the leverage of drug payment standards, and establish an incentive policy of "overexpenditure and reasonable sharing, and incentive retention". We will strengthen the management of medicines and sunlight procurement, and establish a dynamic adjustment mechanism for drug varieties, quality and price. We will improve the standardized construction of integrated management information platforms for national drug supply security and the centralized procurement platform of provincial medicines, and improve the mechanism for data sharing of drug purchasing. (responsibility unit: provincial health and family planning commission, provincial social council, provincial development and reform commission)

(10) strengthen drug purchase and marketing management.

Make purchase and sales contract template, urge the purchase and sale of both parties to sign the contract and strictly perform. Drug production and circulation enterprises should fulfill their social responsibilities to ensure the timely production and delivery of medicines. We will strengthen the supervision over the tripartite transaction, and build a credit archive database for medical institutions, winning companies and distribution enterprises in gansu province. The bank will be introduced to provide cash flow for 30 days. Agreed in violation of the good faith, distribution does not affect clinical medication or refused to provide timely delivery service enterprise in remote areas, giving interviews, informed criticism, warning, and cancel the bid qualification into the blacklist, public hospital 2 years shall not purchase its drugs. Medical institutions such as purchaser to settlement payment for goods in time, in violation of the contract, without any justified reason, not timely collection or disguised extended loan payment cycle of medical institutions, health, family planning department to rectify and criticized, credited to enterprises credit record. As the annual assessment of public hospitals and the annual appraisal of the President, the annual review of medicine is important. (responsibility unit: provincial health and family planning commission)

(11) to improve the outstanding problem of drug circulation.

1. Carry out special treatment for outstanding problems of drug operation enterprises. To crack down on loan business licenses, false trading, falsified records, illegal channels selling drugs, commercial bribery, fraud, price monopoly price and forge or falsely making out invoice violation behavior, seriously punish illegal enterprises and medical organizations in accordance with the law and accountable those responsible; If the suspect is suspected of committing a crime, he shall be transferred to the judicial organ in a timely manner. To verify the violation behavior, recorded in drug purchase record, enterprises credit and personal credit records and in accordance with the provisions, public, public hospitals may not buy 2 years related enterprise medicines; If the recidivism or the plot is heavier, the penalty shall be further increased in accordance with the law, and the cost of illegal violation shall be increased. (responsible unit: provincial food and drug administration, provincial health and family planning commission, provincial development and reform commission, provincial public security bureau, provincial tax bureau, provincial local taxation bureau)

2. Strengthen the filing management of medical representatives. To establish "a medical representative management platform", will the entire province pharmaceutical production and management enterprises into medical representatives platform register put on record, the dynamic management, information platform to queries from the public, fully launched social supervision strength, let the medical staff and the public to supervise its legal status and the promotion behavior. The medical representative shall not undertake the sales task of the drug, and the relevant departments shall record the illegal sales of the drug in the personal credit record in real time. (responsibility unit: provincial food and drug administration, provincial health and family planning commission)

Strengthening price information monitoring.

1. Improve the drug price monitoring system, improve the system of drug price monitoring and reporting, further improve the monitoring of drug prices, and timely release monitoring information to the society. To supervise and promote drug production enterprises in the province to complete the delivery price information of the products on schedule. Price information platform, establish a unified across departments and drug centralized purchasing platform (public resources trading platform), the medical insurance payment platform, interconnection, strengthen with the relevant tax data sharing. (responsible unit: provincial development and reform commission, provincial health and family planning commission, provincial food and drug administration bureau, provincial tax bureau, provincial local taxation bureau)

2. Strengthen the price regulation of inadequately competitive drugs. We should timely study and analyze the drugs that reflect strong social reflection, abnormal price fluctuation or the difference in price of the same varieties, and carry out the special investigation of cost price when necessary. (responsibility unit: provincial development and reform commission)

(13) promote the "Internet + drug circulation".

1. Guide the development of "Internet + pharmaceutical circulation". Guide for the Internet drug sales and retail chain enterprise actively promote online integration development, relying on the entity shop, take "the net book store take", "net book store send" new sales and distribution in the Internet sales of over-the-counter (OTC) drugs; We will encourage drug distribution enterprises to make full use of information technologies such as Internet, Internet of things, big data and cloud computing to improve the information level of drug marketing, payment and after-sales services. (responsibility unit: provincial food and drug administration, provincial party committee, provincial Commerce Department)

2. Promote the development of Internet pharmaceutical services. We will encourage large drug retail chains to rely on the Internet to carry out online pharmaceutical services for pharmacists, guide rational use of medicines, and improve the safety of drug purchases by the masses. (responsibility unit: provincial food and drug administration, ministry of industry and information technology)

Iii. Standardize medical treatment and drug use, and reform and adjust the profit-driven mechanism

Promote rational use of drugs.

1. Strengthen rational drug administration. Public hospitals should be equipped with basic drugs. Medical institutions should make use of drug procurement as an important part of public administration, and disclose the price, dosage and proportion of drugs in each season. Training, evaluation, strengthen the rational use of drugs to carry out the prescription reviews, evidence-based medicine of traditional Chinese medicine and other regulations, focus on monitoring the use of antibiotics, adjuvant drugs, nutritional drugs, prescription the doctor of irrational use of antibiotics to the public, and set up the system of appointment. To evaluate the reasonable use of medical institutions, the assessment results are linked to the assessment of the dean's evaluation and performance salary. (responsibility unit: provincial health and family planning commission)

2. Expanded clinical pathway coverage. By the end of 2020, the hospital will carry out clinical path management in the whole province. We will increase the number of medical institutions and departments that carry out clinical pathway management, and improve the total number of clinical pathway management cases, the rate of entry and completion rate. (responsibility unit: provincial health and family planning commission)

To further break the mechanism of medical treatment.

1. Continuously promote the comprehensive reform of public hospitals. Insist on medical treatment, health care, medicine, linkage, push forward to cancel the drug addition, the adjustment of medical service price, payment and implement the responsibilities for government investment, reform and the hospital accounting, saving operation cost, etc., medicare payments, health insurance fees policy to connect with each other. Reasonable adjustment is medical personnel technical labor value of medical service price, to lower the price of large medical equipment examination treatment and inspection and drug, consumables, such as cost of room, dynamic adjustment of medical service prices. We will establish a scientific and rational multi-party compensation mechanism and improve the compensation mechanism for public hospitals. (responsibility unit: provincial health and family planning commission, provincial development and reform commission, provincial finance department, provincial social hall)

2. Promote the separation of medicine. Medical institutions should provide prescriptions to patients according to the general name of the drug. Outpatient patients can choose to buy medicine in medical institutions or retail pharmacies, and medical institutions should not limit the patient's prescription to retail pharmacy. (responsibility unit: provincial health and family planning commission)

3. Strictly control the irrational growth of medical expenses. Reasonable determination and quantization of the growth of medical expenses and the implementation of medical institutions. Medical cost control situation and public hospital financial aid and PingXian recommendation, merit pay for approval and caries, dean of the hook, the short of control cost target of the hospital, a pause in its rating review access, new beds and large equipment equipped with qualification examination and approval, as the case subtract or cancel the budget, project schedule, and the corresponding management responsibility shall be investigated for the hospital. Control the proportion of drug use outside of the directory and be linked to insurance payments. (responsibility unit: provincial health and family planning commission, provincial social department, provincial finance department)

(16) to strengthen the role of insurance regulations and control costs.

1. Strengthen the behavior of health insurance regulation. Promote the reform of "3 d" linkage, give full play to the medical insurance of medical service, medical expenses control and supervision, health supervision of medical institutions will be extended to the regulation of medical staff medical services. We will explore the establishment of the credit rating management and blacklist management system of medical insurance institutions. Strengthening the management of agreement and detailed specification agreement, to promote medical institutions to ginseng protect personnel to provide reasonable excellent basic medical services, make active regulating medical behavior of medical institutions, reduce running cost. (responsibility unit: provincial social bureau, provincial health and family planning commission)

2. Timely revise the health care drug catalog. According to the current laws and regulations and documents, we will make the adjustment of b drugs, and the local basic medical insurance, inductrial injury insurance and maternity insurance medicines will be released by July 31, 2017. The number of adjustments (including adjustment, adjustment and adjustment of the limit of payment) shall not exceed 15% of the number of countries in the state. (responsibility unit: provincial social bureau, provincial health and family planning commission)

3. Deepening reform of the payment method for health care. Full implementation of the total amount of pay of insurance of primary medical treatment to control in the whole province, strengthen the fund operation risk prevention, on the basis of combining with the fund budget management, further deepen the reform of the mode of payment, steadily push forward according to single diseases, according to the man's head, the press disease group (DRGs), and other payment method reform, promote the standardize medical service, medical institutions to control costs, reasonable standards medicare payments. (responsibility unit: provincial social bureau, provincial health and family planning commission)

4. In-depth research on innovation of healthcare management mechanism. We will standardize the policy of supplementary medical insurance for employees, strengthen the connection of various medical insurance systems, explore the reform of the individual accounts of employees, and set up an outpatient care system for employees. Combining information system construction, promoting intelligent monitoring and social insurance drug classification and code industry standard application. Explore the establishment of long-term care insurance system. (responsibility unit: provincial social bureau, provincial health and family planning commission)

(17) actively play the role of pharmacists.

1. Implement the rights and responsibilities of pharmacists and give full play to the role of pharmacists in rational drug use. Medical institutions should be equipped with clinical pharmacists, and clinical pharmacists should participate full time in clinical drug therapy and guide patients' safe use of drugs. The prescription review and adjustment of pharmacists, guidance of clinical medication, standardization of medicine, etc., explore reasonable compensation approaches, and do well in connection with policies such as health insurance. (responsibility unit: provincial health and family planning commission, provincial social department)

2. Strengthen training and use of pharmacists in retail pharmacies. Rationally plan and allocate the resources of pharmaceutical talents, strengthen the digital identity management, and strengthen the team construction of pharmacists. Take the city as the unit, explore various forms to organize the retail pharmacy pharmacist training, promote pharmacy pharmacist's medicine service ability and level. In combination with daily supervision and inspection, we should strengthen supervision over the on-the-job of licensed pharmacists and carry out prescription audit duties. (responsibility unit: provincial food and drug administration, provincial social hall)

Office of the people's government of gansu province

August 31, 2017


 
Previous article:Fifty-five hospitals, 45 drugs to use!
Next article:增速超20%!四大品種引領抗體藥沖刺百億市場
 
Log in  Website Map All right reserved by China Mingxuan, Guangzhou ICP #16026227
    

粵公網安備 44011202000029號